Zimmer Biomet Holdings, Inc. (ZBH) stock
Close on Nov 12, 2026Market cap $19.94BP/E 26.5Yield 0.92%
Zimmer Biomet Holdings, Inc. grew revenue 7.0% to $8.57B over the twelve months to Sep 30, 2026. Operating income fell 12.8% to $1.16B, moving the operating margin from 16.6% to 13.6%. Free cash flow was $1.64B, up 10.7% from a year earlier. At the latest close the market valued the company at $19.94B, 26.5 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $19.94B
- P/E ratio
- 26.5
- Price to sales
- 2.33
- Price to book
- 1.57
- Dividend yield
- 0.92%
- Free cash flow yield
- 8.24%
Fundamentals
- Revenue
- $8.57B
- Net income
- $767.30M
- EPS, diluted
- $3.95
- Free cash flow
- $1.64B
- Book value per share
- $66.43
- Diluted shares
- 191M
Trading
- Next earnings
- Feb 9, 2027 (estimated, before the open)
- Previous close
- $107.47
- Open
- $108.39
- Day's range
- $104.24 – $108.99
- Volume
- 1,668,140
- Average volume (20 days)
- 2,379,989
- Index membership
- S&P 500, Russell 1000, Russell 3000
- Beta (5 years)
- 0.66
- 52-week range
- $79.12 – $112.55
- RSI (14 days)
- 58.7
- Volatility (1 year)
- 32.4%
- Relative volume
- 0.76×
- WACC
- 7.7%
Index membership is inferred from the holdings of funds that track each index (VOO, IVV, SPYM, IWB, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2009, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | ZBH | S&P 500 | Difference | ZBH per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +13.4% | -2.7% | +16.1 pts | ||
| 3 months | +7.1% | -1.7% | +8.8 pts | ||
| Year to date | +17.2% | +11.9% | +5.3 pts | ||
| 1 year | +17.4% | +12.0% | +5.4 pts | ||
| 3 years | +2.0% | +78.2% | −76.1 pts | +0.7% | +21.2% |
| 5 years | -15.0% | +73.2% | −88.2 pts | -3.2% | +11.6% |
| 10 years | +19.4% | +309.6% | −290.3 pts | +1.8% | +15.1% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Zimmer Biomet filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- News
- Results
- Update
- Update
About Zimmer Biomet
Orthopedic, Prosthetic & Surgical Appliances & Supplies
The provided excerpt consists solely of raw XBRL taxonomy tags, accounting data, and SEC filing metadata without explanatory narrative detailing the entity's core operations or commercial activities. Inferred from product line and segment identifiers, the company operates in medical products and devices, featuring offerings and operating segments associated with knees, hips, surgical equipment, bone cement, and healthcare data technology. The provided text contains no details or statements identifying its end users or customers.
Company profile, executives and historyZimmer Biomet stock: common questions
What is Zimmer Biomet's stock price?
ZBH closed at $104.56 on Nov 12, 2026, down 2.71% on the day. Over the past 52 weeks it traded between $79.12 and $112.55.
What is Zimmer Biomet's market cap?
Zimmer Biomet was worth $19.94B at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is ZBH's P/E ratio?
ZBH trades at 26.5 times earnings, based on diluted earnings per share of $3.95 over the twelve months to Sep 30, 2026.
How much revenue does Zimmer Biomet make?
Zimmer Biomet reported revenue of $8.57B for the twelve months to Sep 30, 2026, up 7.0% from a year earlier.
Does Zimmer Biomet pay a dividend?
Yes. Zimmer Biomet paid $0.96 per share over the last twelve months, a yield of 0.92% at the latest price.
When does Zimmer Biomet report earnings next?
Zimmer Biomet is expected to report Q4 FY2026 results on Feb 9, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has ZBH stock performed over the past year?
Including dividends, ZBH returned +17.4% over the past year, against +12.0% for the S&P 500.
How many ZBH shares are sold short?
8M shares were sold short at the latest FINRA report, 4.12% of the float, or 3.9 days of average trading volume.
Who are Zimmer Biomet's competitors?
Companies most similar to Zimmer Biomet by business, industry and size include SNN, PHG, STE, ISRG, SYK.
See a number that looks wrong?